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Background/introduction
Magnetic resonance guided focused ultrasound surgery
(MRgFUS) of the musculoskeletal system achieved sig-
nificant results in the treatment of painful bone metas-
tases, and recently showed promise for benign bone
lesions (e.g. osteoid osteoma) and osteoarthritis (e.g.
facet joint syndrome and knee osteoarthritis). MRgFUS
works on the main basis of pain relief and tumor control
/ killing. In this case review five patients affected by
different diseases not commonly treated by MRgFUS are
presented.
Methods
(A) A patient suffering from femuroacetabular impinge-
ment developed a small focal lesion in the anterosuper-
ior profile of the femoral neck (herniation pit). The
lesion was harshly painful at baseline (visual analogue
scale score – VAS 9), with severe mobility impairment.
Conservative treatments failed and the patient was in
list for arthroplasty. (B and C) In 2 patients, the targeted
lesion was a small (about 1 cm) subcortical alteration of
the posterosuperior profile of the femoral neck, diag-
nosed as a focal degenerative change caused by posterior
impingement syndrome. At baseline patients suffered
from pain (VAS 9 and 8, respectively) and relevant
mobility impairment like in case A; both patients started
with symptoms several months before and they were
unsuccessfully treated by drugs and surgery (arthro-
scopic approach – male patient). (D) A patient was
found with a 1-cm sclerotic alteration of the 8th right
rib, dimensionally stable at 6-month imaging follow-up;
scintigraphy and FDG positron emission tomography
were both negative, with no nidus or other signs
detected by CT or perfusion MR. No history of oncolo-
gical disorders. The lesion was painful (VAS 9), and pre-
vious treatments (systemic drugs, local injections) failed
in controlling pain. We decided to proceed to MRgFUS
without histological diagnosis (fibrous dysplasia, osteoid
osteoma or osteitis were the most likely hypotheses). (E)
Another patient with aggressive fibromatosis presented
with a 10-cm mass extended from the left popliteal
fossa to the leg; the patient previously underwent several
surgical sessions, radiation therapy and pharmacological
treatment throughout two decades, particularly over the
site of the presented fibroma (large scars, venous varicosity
and incontinence, and arterial bypass). The patient suf-
fered from relapses and also infective and vascular compli-
cations. All patients were examined clinically and by
imaging, before treatment (ExAblate 2100, InSightec) and
up to 12 months of follow-up (1-, 3-, 6- and 12-month
checks).
Results and conclusions
Patients with focal degenerative diseases (A, B, and C)
showed an excellent response to treatment: VAS dropped
to 0 after 1 month and persisted to 0 in all the subsequent
follow-up controls (12 months), with significant improve-
ment in the mobility of the affected hip. The patient (D)
with rib lesion of unknown origin had only a partial
improvement (VAS from 9 to 6 after 1 month, the only
check reached).
The patient affected by fibromatosis showed VAS flat-
tening to 0 (1-month check) with improvement of the per-
ceived quality of life. The lesion showed dimensional
reduction and no enhancement at contrast media injection
from the 3-month control (6 months of follow-up). Several
and different applications of MRgFUS in musculoskeletal
disorders are coming, to find an effective solution or to
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minimize invasivity and avoid or postpone any major
intervention.
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